The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery
Abstract
The blood-brain barrier (BBB) can be temporarily and locally opened by focused ultrasound (FUS) in the presence of circulating microbubbles (MBs). Currently, contrast-enhanced magnetic resonance imaging (CE-MRI) is used to monitor contrast agent leakage to verify BBB-opening and infer drug deposition. However, despite being administered concurrently, MBs, therapeutic agent, and contrast agent have distinct pharmacodynamic behaviors, thus complicating the quantification and optimization of BBB-opening and drug delivery. Here we propose multifunctional MBs loaded with therapeutic agent (doxorubicin; DOX) and conjugated with superparamagnetic iron oxide (SPIO) nanoparticles. These DOX-SPIO-MBs were designed to concurrently open the BBB and perform drug delivery upon FUS exposure, act as dual MRI and ultrasound contrast agent, and allow magnetic targeting (MT) to achieve enhanced drug delivery. We performed burst-tone FUS after injection of DOX-SPIO-MBs, followed by MT with an external magnet attached to the scalp in a rat glioma model. Animals were monitored by T2-weighted MRI and susceptibility weighted imaging and the concentration of SPIO particles was determined by spin-spin relaxivity. We found that DOX-SPIO-MBs were stable and provided significant superparamagnetic/acoustic properties for imaging. BBB-opening and drug delivery were achieved concurrently during the FUS exposure. In addition, MT increased local SPIO deposition in tumor regions by 22.4%. Our findings suggest that DOX-SPIO-MBs with FUS could be an excellent theranostic tool for future image-guided drug delivery to brain tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SPION-labeling in combination with MRI (and recently also MPI) has been the method of choice for cell tracking [193, 255].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [255]
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Omid Veiseh, A., Gunn, J., & Zhang, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,854
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,811
Recent advances in iron oxide nanocrystal technology for medical imaging☆
Corot, C., Robert, P., Idée, J., & Port, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.013 · Cited by 1,498
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N. J., Vykhodtseva, N. I., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,463
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C. J., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 905
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C.-M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 901
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Sheikov, N. A., McDannold, N. J., Vykhodtseva, N. I., Jolesz, F. A., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 619
Cited by
Sorted by citations
Items 101–200 of 225
Progress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics
Thorat, N. D., Townely, H., Brennan, G., Parchur, A. K., Silien, C., Bauer, J., & Tofail, S. A. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01173 · Cited by 40
Treatment of Movement Disorders With Focused Ultrasound
Fishman, P. S., & Frenkel, V. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517705670 · Cited by 44
Fan, C., & Yeh, C. (2014) · Journal of Medical Ultrasound · doi:10.1016/j.jmu.2014.11.001 · Cited by 38
Dong, C., Hu, H., Sun, L., & Chen, Y. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abef58 · Cited by 37
Focused Ultrasound Mediated Opening of the Blood-Brain Barrier for Neurodegenerative Diseases
Fishman, P. S., & Fischell, J. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.749047 · Cited by 40
Li, H., Jin, Z., Cho, S., Jeon, M. J., Nguyen, V. D., Park, J., & Park, S. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8477 · Cited by 36
Martinez, P. J., Green, A. L., & Borden, M. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.037 · Cited by 38
Rapid In Situ MRI Traceable Gel-forming Dual-drug Delivery for Synergistic Therapy of Brain Tumor
Lin, F., Chen, P., Wei, K., Huang, C.-Y., Wang, C., & Yang, H. (2017) · Theranostics · doi:10.7150/thno.19856 · Cited by 35
Barnsley, L. C., Carugo, D., Aron, M., & Stride, E. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa5d46 · Cited by 35
He, C., Wu, Z., Zhuang, M., Li, X., Xu, S., Xu, S., Xu, J., Wu, Z., & Lu, M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02074-z · Cited by 33
“Thus, magnetic targeting (MT) is used to actively enhance drug deposition at the target site, potentially increasing the therapeutic dose compared to passive diffusion [12].”
BackgroundControlled assembly of magnetic nanoparticles on microbubbles for multimodal imaging
Duan, L., Yang, F., Song, L., Fang, K., Tian, J., Liang, Y., Li, M., Xu, N., Chen, Z., Zhang, Y., et al. (2015) · Soft Matter · doi:10.1039/c5sm00864f · Cited by 33
Rich, M. C., Sherwood, J. A., Bartley, A. F., Whitsitt, Q. A., Lee, M., Willoughby, W. R., Dobrunz, L. E., Bao, Y., Lubin, F. D., & Bolding, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.054 · Cited by 33
“…2014; Hynynen et al. 2001) however, contrast agents and target drugs can have different pharmacodynamic properties, thus novel drug-contrast constructs have been developed for more accurate monitoring of drug delivery (Fan et al. 2013; Alford et al. 2018; Maboudi et al. 2019; Sherwood et al. 2017).”
BackgroundMcMahon, D., Mah, E., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-30825-8 · Cited by 34
Wen, M., Liu, X., Yu, N., Qiu, P., Macharia, D. K., Li, M., Zhang, H., Chen, Z., & Lian, W. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.06.116 · Cited by 32
The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma
Wegscheid, M. L., Morshed, R. A., Cheng, Y., & Lesniak, M. S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912629 · Cited by 30
“combined the BBB disruption power of focused ultrasound (FUS) with microbubbles encapsulating doxorubicin (DOX) and superparamagnetic iron oxide nanoparticles (SPIONs) [24].”
BackgroundDrug-Loaded Microbubbles Combined with Ultrasound for Thrombolysis and Malignant Tumor Therapy
Gong, Q., Gao, X.-X., Liu, W.-F., Hong, T., & Chen, C. (2019) · BioMed Research International · doi:10.1155/2019/6792465 · Cited by 23
“04 μm Glioblastoma multiforme Investigating the efficiency of opening BBB and drug delivery [70]”
BackgroundBérard, C., Truillet, C., Larrat, B., Dhermain, F. G., Estève, M., Corréard, F., & Novell, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108518 · Cited by 32
Deng, Z., Sheng, Z., & Yan, F. (2019) · Journal of Oncology · doi:10.1155/2019/2345203 · Cited by 30
“designed an SPIO-labeled phospholipid-based microbubbles, with doxorubicin (DOX) incorporated in it [53].”
BackgroundKim, E., & Jeong, H. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0435-8 · Cited by 32
Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma
Aguiar, M. F. D. P., Mamani, J. B., Souza, T. K. F., dos Reis, R. F., da Silva, H. R., Nucci, L. P., Nucci, M. P., & Gamarra, L. F. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0101 · Cited by 28
Wen, M., Shen, J., Wang, Z., Guo, H., Geng, P., Yu, N., Li, M., Zhang, H., Zhu, M., & Chen, Z. (2021) · Nanoscale · doi:10.1039/d0nr08508a · Cited by 28
Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors
Askoxylakis, V., Arvanitis, C., Wong, C. S. F., Ferraro, G. B., & Jain, R. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.011 · Cited by 27
Yang, S., Wang, P., Wang, X., Su, X., & Liu, Q. (2014) · European Radiology · doi:10.1007/s00330-014-3334-3 · Cited by 27
Magnetic particles in motion: magneto-motive imaging and sensing
Kubelick, K. P., & Mehrmohammadi, M. (2022) · Theranostics · doi:10.7150/thno.54056 · Cited by 30
Nogueira-Librelotto, D. R., Scheeren, L. E., Vinardell, M. P., Mitjans, M., & Rolim, C. M. B. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.014 · Cited by 27
Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
Fu, L., Fu, L., Ke, H., & Ke, H. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0065 · Cited by 27
Nanoprobe-mediated precise imaging and therapy of glioma
Tang, T., Chang, B., Zhang, M., & Sun, T. (2021) · Nanoscale Horizons · doi:10.1039/d1nh00182e · Cited by 25
Biological identity of nanomaterials: Opportunities and challenges
Deng, J., Yu, D.-H., & Gao, C. (2013) · Science China Chemistry · doi:10.1007/s11426-013-4972-z · Cited by 25
Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases
Melancon, M. P., Figueira, T. A., Fuentes, D., Li, T., Qiao, Y., Gu, J., Gagea, M., Ensor, J., Muñoz, N. M., Maldonado, K. L., et al. (2017) · Radiology · doi:10.1148/radiol.2017161721 · Cited by 25
Design and Implementation of a Transmit/Receive Ultrasound Phased Array for Brain Applications
Liu, H.-L., Tsai, C.-H., Jan, C.-K., Chang, H.-Y., Huang, S., Li, M., Qiu, W., & Zheng, H. (2018) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2018.2855181 · Cited by 25
“culation during focused ultrasound exposure has been shown to temporally induced a blood–brain barrier (BBB) opening effect [7], [8] and to have potential for the delivery of small-molecule anticancer drugs [9]–[11], macromolecular monoclonal antibodies [12], [13], novel theranostic nanoparticles [14], [15], or genes…”
BackgroundLázaro-Carrillo, A., Calero, M., Aires, A., Cortajarena, A. L., Simões, B. M., Latorre, A., Somoza, Á., Clarke, R. B., Miranda, R., & Villanueva, Á. (2020) · Cancers · doi:10.3390/cancers12061397 · Cited by 24
“In relation to this fact, similar results have been described for other magnetic nanoparticles [23,24].”
ResultOvercoming the Blood-Brain Barrier in Chemotherapy Treatment of Pediatric Brain Tumors
Wu, L., Li, X., Janagam, D. R., & Lowe, T. L. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1196-z · Cited by 24
Kuo, T., Wang, C., Wang, J., Chiou, H., Fan, C., & Yeh, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050223 · Cited by 23
“To load the bubbles with DOX molecules, a DOX aqua solution (with deionized water, in the concentration of 10 mg/mL) was injected into pure bubbles without drug loading agent (Deliver) to mix with the formulated lipids [14,16].”
BackgroundMethodMagnetic black phosphorus microbubbles for targeted tumor theranostics
Zhu, Y., Liu, Y., Xie, Z., He, T., Su, L., Guo, F., Arkin, G., Lai, X., Xu, J., & Zhang, H. (2021) · Nanophotonics · doi:10.1515/nanoph-2021-0085 · Cited by 23
Zhang, X., Hu, J., Zhao, G., Huang, N., Tan, Y. C., Pi, L., Huang, Q., Wang, F., Wang, Z., Wang, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17155 · Cited by 22
Gold nanoflower‐based surface‐enhanced Raman probes for pH mapping of tumor cell microenviroment
Xie, M., Li, F., Gu, P., Wang, F., Qu, Z., Li, J., Wang, L., Zuo, X., Zhang, X., & Shen, J. (2019) · Cell Proliferation · doi:10.1111/cpr.12618 · Cited by 20
Tan, J., Sun, W., Lu, L., Xiao, Z., Wei, H., Shi, W., Wang, Y., Han, S., & Shuai, X. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01563a · Cited by 21
Xia, X., Xiang, X., Huang, F., Zhang, Z., & Han, L. (2017) · Chemical Communications · doi:10.1039/c7cc07615k · Cited by 20
Garg, K., Ranjan, M., Krishna, V., Singh, M., & Rezai, A. R. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.981571 · Cited by 19
Targeted and theranostic applications for nanotechnologies in medicine
Setua, S., Jaggi, M., Yallapu, M. M., Chauhan, S. C., Aleksandrovna, D. A., Lee, H., Choi, I. S., Fakhrullin, R. F., Esposti, L. D., Tampieri, A., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00006-x · Cited by 20
Towards tailored management of malignant brain tumors with nanotheranostics
Aparicio-Blanco, J., & Torres‐Suárez, A. I. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.029 · Cited by 18
Almalki, W. H., Alghamdi, S. A., Alzahrani, A., & Zhang, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.018 · Cited by 17
Dong, F., An, J., Guo, W., Dang, J., Huang, S., Feng, F., Zhang, J., Wang, D., Yin, J., Fang, J., et al. (2024) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2024.106854 · Cited by 17
“However, typical tumors have fenestrate openings ranging from 400 nm to 600 nm [12], making it difficult for MBs with a size of several microns to penetrate the leaky tumor vasculature and target cancer cells [13].”
BackgroundDias-Carvalho, A., Ferreira, M., Reis-Mendes, A., Ferreira, R. M., Bastos, M. D. L., Fernandes, E. G. R., Sá, S. I., Capela, J. P., Carvalho, F. D., & Costa, V. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31608 · Cited by 17
“Thus, neither DOX nor its main metabolite, doxorubicinol, are detected in significant amounts in the brain after systemic administration [15], with the exception of when delivered in nanosystems [16].”
BackgroundMaritim, S., Coman, D., Huang, Y., Rao, J. U., Walsh, J. J., & Hyder, F. (2017) · Contrast Media & Molecular Imaging · doi:10.1155/2017/3849373 · Cited by 17
Fu, J.-W., Lin, Y., Gan, S., Li, Y.-R., Wang, Y., Feng, S., Li, H., & Zhou, G. (2019) · Contrast Media & Molecular Imaging · doi:10.1155/2019/3145647 · Cited by 17
“proposed DOX and SPION-loaded microbubbles (DOX-SPIO-MBs) to concurrently open the BBB upon focused ultrasound exposure for precise drug delivery [87].”
BackgroundSong, S., Guo, H., Jiang, Z., Jin, Y., Wu, Y., An, X., Zhang, Z., Sun, K., & Dou, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.025 · Cited by 16
Polymer microbubbles as universal platform to accelerate polymer mechanochemistry
Fan, J., Lennarz, R., Zhang, K., Mourran, A., Meisner, J., Xuan, M., Göstl, R., & Herrmann, A. (2025) · Nature Communications · doi:10.1038/s41467-025-60667-8 · Cited by 15
Microbubble Delivery Platform for Ultrasound-Mediated Therapy in Brain Cancers
Kim, K., Lee, J.-M., & Park, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020698 · Cited by 15
Lin, C.-W., Fan, C., & Yeh, C. (2023) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2023.106728 · Cited by 15
Wang, Z., Zhu, J., Chen, Y., Geng, K., Nong, Q., Cheng, L., Lu, Z., Pan, Y., Guo, L., Li, Y., et al. (2013) · RSC Advances · doi:10.1039/c3ra45878d · Cited by 15
Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors
Chen, Z., Sang, L., Qixi, Z., Li, X., Liu, Y., & Bai, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101661 · Cited by 15
“By incorporating MnO 2 [158], DOTA-Gd [152], and superparamagnetic iron oxide [159], MRI-guided MB-FUS therapy for brain tumors can be achieved.”
Chen, P., Yeh, C., Hsu, P., Lin, C., Huang, C.-Y., Wei, K., & Liu, H.-L. (2017) · Oncotarget · doi:10.18632/oncotarget.16218 · Cited by 14
Synthesis of Laboratory Ultrasound Contrast Agents
Park, J., Park, D., Shin, U., Moon, S.-H., Kim, C., Kim, H., Park, H., Choi, K., Jung, B.-K., Oh, J., et al. (2013) · Molecules · doi:10.3390/molecules181013078 · Cited by 14
Štarha, P., Stavárek, M., Tuček, J., & Trávnı́ček, Z. (2014) · Molecules · doi:10.3390/molecules19021622 · Cited by 13
Novel drug-delivery approaches to the blood-brain barrier
Wang, X., Yu, X., Vaughan, W., Liu, M., & Guan, Y. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1498-0 · Cited by 13
Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders
Stavarache, M. A., Chazen, J. L., & Kaplitt, M. G. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.08.052 · Cited by 15
MRI-powered Magnetic Miniature Capsule Robot with HIFU-controlled On-demand Drug Delivery
Tiryaki, M. E., Doğangün, F., Dayan, C. B., Wrede, P., & Sitti, M. (2023) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra48891.2023.10161197 · Cited by 12
“effects allowing vast design possibilities for drug delivery systems [7]–[13] and also can enhance drug diffusion by opening physiological barriers, such as blood-brain barrier [14].”
BackgroundTuřánek, J., Miller, A. D., Kauerová, Z., Lukáč, R., Mašek, J., Koudelka, Š., & Raška, M. (2015) · Advances in Bioengineering · doi:10.5772/59870 · Cited by 12
Solvothermal synthesis of FeCo nanoparticles for magneto-controllable biocatalysis
Hou, J., Kuang, Y., Shen, H., Cao, H., Luo, L., Liu, J., Wan, P., Chen, B., Sun, X., & Tan, T. (2014) · RSC Advances · doi:10.1039/c4ra00417e · Cited by 11
Su, X., Rakshit, M., Das, P., Gupta, I., Das, D., Pramanik, M., Ng, K. W., & Kwan, J. J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01161 · Cited by 11
Liu, Y., Lai, X., Zhu, Y., Guo, F., Su, L., Arkin, G., He, T., Xu, J., & Ran, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121299 · Cited by 11
Yang, H., Wei, K., Lin, F., Huang, C.-Y., Ma, C.-C. M., Chen, J., & Feng, L.-Y. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s113589 · Cited by 11
Development of Drugs and Technology for Radiation Theragnosis
Jeong, H.-J., Lee, B. C., Ahn, B., & Kang, K. W. (2016) · Nuclear Engineering and Technology · doi:10.1016/j.net.2016.04.003 · Cited by 9
Bioapplications of Nanomaterials
Huynh, K.-H., Lee, K.-Y., Chang, H., Lee, S. H., Kim, J., Pham, X., Lee, Y., Rho, W., & Jun, B. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6158-4_10 · Cited by 9
Emerging Therapeutic Strategies for Brain Tumors
Aryal, M., & Porter, T. M. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08681-z · Cited by 8
“…Liu et al., 2010; McDannold et al., 2012; Thévenot et al., 2012), nanoparticles, and biologics (peptides ~ 3 kDa, antibodies ~ 150 kDa, and viruses ~ 2 MDa) (Aryal et al., 2015a; Chen et al., 2010; Diaz et al., 2014; Etame et al., 2012; Fan et al., 2013a; Nance et al., 2014; Wang et al., 2012).”
Multifunctional Ultrasound Microbubbles
Barmin, R. A., Moosavifar, M., Herrmann, A. P., Kiessling, F. M., Lammers, T., & Pallares, R. M. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00280 · Cited by 8
Wu, C.-H., Liu, H.-L., Ho, C., Hsu, P.-H., Fan, C.-H., Yeh, C., Kang, S.-T., Chen, W.-S., Wang, F.-N., & Peng, H.-H. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26801 · Cited by 6
“7,8 The susceptibility effects of microbubbles can be enhanced by embedding superparamagnetic iron oxide nanoparticles on a microbubble shell.(9,10) A variety of methods can be used to identify the BBB opening after inducing an FUS cavitation effect in the presence of microbubbles.”
BackgroundFeng, Y., Li, J., & Zhang, X. (2022) · BioMed Research International · doi:10.1155/2022/7911801 · Cited by 7
RetractedWu, S.-Y., Chen, C., Tung, Y., Olumolade, O., & Konofagou, E. E. (2015) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2015.0100 · Cited by 7
Rich, M. C., Whitsitt, Q. A., Lubin, F. D., & Bolding, M. (2020) · Journal of Visualized Experiments · doi:10.3791/61113 · Cited by 6
Polymer-Based Materials and their Applications in Image-Guided Cancer Therapy
Sun, Y., Ran, H., & Liu, F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210616160717 · Cited by 6
THE APPLICATION OF NANOMATERIALS IN DIAGNOSIS AND TREATMENT FOR MALIGNANT PRIMARY BRAIN TUMORS
Liang, R., & FANG, F. (2013) · NANO · doi:10.1142/s1793292014300011 · Cited by 5
Drug Delivery Across the Blood–Brain Barrier with Focused Ultrasound and Microbubbles
Meairs, S. P. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_37 · Cited by 5
Skachkov, I., Luan, Y., van Tiel, S. T., van der Steen, A. F. W., de Jong, N., Bernsen, M. R., & Kooiman, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204354 · Cited by 5
“5) applied for 90 s; MRI performed 40 min after treatment [34] or 1 MHz with 5,000 cycles and repetition rate of 1 Hz at 300 kPa (MI 0.”
BackgroundMethodIn vitro Preparation and Characterization of Magnetic Nanobubbles
Yi, X., Abenojar, E., Zhu, J., Zheng, Y., & Exner, A. A. (2019) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2019.8925956 · Cited by 5
“The MRI performance of the magnetic nanobubbles was also evaluated by measuring the T2 relaxation rates of the samples at different Fe concentrations using a 1.5 T 60 MHz Bruker Minispec NMR relaxometer (Fig.”
BackgroundInfluentialDrug Delivery to the Central Nervous System
Sriraman, S., Salzano, G., & Torchilin, V. (2017) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-0-12-803058-5.00041-2 · Cited by 1
An overview of focused ultrasound as a treatment option for gliomas
Hey, G. E., DeYoung, C. L., Dagra, A., Gillam, W. B., V, & Lucke-Wold, B. P. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2534615 · Cited by 4
Thermo- and ultrasound-responsive polysaccharides for controlled drug delivery
Soni, S. R., & Ghosh, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102553-6.00009-x · Cited by 4
Magnetic Nanomaterials for Therapy
Ling, D., & Hyeon, T. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527803255.ch13 · Cited by 4
Polymeric Biomaterials for Medical Diagnostics in the Central Nervous System
Yin, Y., Rassias, D., & Jain, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396983-5.00023-5 · Cited by 4
Kee, H., Lee, H., Park, J., Jang, S., & Park, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114408 · Cited by 3
Chen, J., Zhao, C., Liu, H., Wang, Z., Ma, L., Zhang, J., Xu, N., Hu, K., & Duan, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1323056 · Cited by 3
Dong, W., Wang, G., Chai, Y., Li, W., Liu, S., Liu, H., Guo, W., Li, S., He, X., Wan, M., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01828-6 · Cited by 5
Drug Delivery to the Brain via Focused Ultrasound
Arvanitis, C., & McDannold, N. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800870-6.00018-2 · Cited by 3
Surface-functionalized magnetic nanoparticles in cancer-drug delivery and diagnosis
Shah, M. R., Imran, M. A., & Ullah, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816773-1.00005-5 · Cited by 3
Image Guided Focused Ultrasound as a New Method of Targeted Drug Delivery
Wright, M., Centelles, M. N., Gedroyc, W. M. W., & Thanou, M. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788010597-00001 · Cited by 3
Hoang, T. N., Lin, H.-C., Tsai, C.-H., Jan, C.-K., & Liu, H.-L. (2022) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-022-00735-2 · Cited by 3
Sarwal, A., Singh, G., Prasad, P., Sharma, S., & Ali, W. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_9 · Cited by 2
Image-Guided Delivery of Therapeutics to the Brain
Shah, L. K., Iyer, A. K., Talekar, M., & Amiji, M. M. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_4 · Cited by 2
WITHDRAWN: Polymer assembly: Promising carriers as co-delivery systems for cancer therapy
Li, N., Zhao, L., Qi, L., Li, Z., & Luan, Y. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.11.002 · Cited by 2
Zamboni, C. G., Farahani, K., & Green, J. J. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_15 · Cited by 2
Accessing the Blood-Brain Barrier to Treat Brain Disorders
Sureshkumar, M., & Pandian, A. (2019) · Current Nanomedicine · doi:10.2174/2468187309666190823154318 · Cited by 2
Fan, C., Hsieh, Y., Ting, C.-Y., Liu, H.-L., Wang, C., & Yeh, C. (2013) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2013.0534 · Cited by 1
Palumbo, A., & Versaci, M. (2025) · Mathematics · doi:10.3390/math13152540 · Cited by 1
Sonodynamic and magnetic targeting platelet-membrane biomimetic platform for glioblastoma therapy
Zou, S., Zhang, Y., Mao, S., Yuan, M., & Yang, J. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1648167 · Cited by 1
Ultrasound-mediated targeted micro/nanobubbles: breaking new boundaries in precision tumor therapy
Yang, M., Zhang, Z., Zhou, H., Luo, Z., Wang, Y., Li, S., Liu, Z., & Zhang, X. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004796 · Cited by 2
Overcoming therapeutic resistance in oncology: The prospects of inorganic nanotheranostics
Zhang, W., Ma, J., Yanagi, Y., Yin, P., Cheng, J., Wang, Y., Hong, N., Ricke, J., Xue, H., & Cheng, S. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101361 · Cited by 1
Multifunctional Ultrasound Contrast Agents Integrating Targeted Imaging and Therapy
Gao, C., & Dai, Z. (2016) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-10-0063-8_4 · Cited by 1
Mechanisms of Actively Triggered Drug Delivery from Hard Nanoparticle Carriers
Sangtani, A., Muroski, M. E., & Delehanty, J. B. (2019) · ACS symposium series · doi:10.1021/bk-2019-1309.ch008 · Cited by 1
Metadata
- Authors
- Fan, C.-H., Ting, C.-Y., Lin, H.-J., Wang, C.-H., Liu, H.-L., Yen, T.-C., & Yeh, C.-K.
- Affiliations
- National Tsing Hua University (TW)
- Chang Gung University (TW)
- Corresponding author
- Liu, Hao-Li
- Yeh, Chih-Kuang
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 34
- Issue
- 14
- Pages
- 3706-3715
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2067444098
- Cited by
- 225
- References
- 36
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 17 · 2020: 11 · 2019: 25 · 2018: 18 · 2017: 24 · 2016: 24 · 2015: 26 · 2014: 26 · 2013: 9
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Council of Taiwan (100-2218-E-182-001, 101-2627-M-007-001, 101-2221-E-007-035-MY3)
- National Tsing Hua University (102N2050E1)
- Taiwan National Health Research Institutes (NM-101-PP-04)
- Materials Analysis Technology Inc. Corporation
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- superparamagnetic iron oxide nanoparticles, microbubbles, doxorubicin, focused ultrasound, blood-brain barrier opening, brain tumor drug delivery, magnetic targeting, theranostics, image-guided drug delivery, glioma, MRI contrast agents, ultrasound contrast agents, susceptibility-weighted imaging
- MeSH terms
- Animals, Brain Neoplasms, Doxorubicin, Ferric Compounds, Magnetic Resonance Imaging, Male, Drug Delivery Systems, Rats, Sprague-Dawley, Microbubbles, Cell Line, Tumor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review